Clinical Trial Update: Study of Oral Topotecan With Bevacizumab for Recurrent Small Cell Lung Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating oral topotecan in combination with bevacizumab for recurrent small cell lung cancer has completed and results have been post…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small Cell Lung Cancer

Drugs mentioned

• Bevacizumab (bevacizumab)
• Topotecan (topotecan)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Recurrent Small-cell Lung Cancer (SCLC), Lung Cancer, Small Cell | Phase 2 | Status: COMPLETED | Results posted: 2011-02-03